Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

GomSpace - Strategic direction & Q&A

By HC Andersen Capital
GomSpace Group

You can already now sign up for the event and submit your questions. You don’t have to participate live to submit questions for the event.

On Monday the 19th of January at 14:00, we will host an event with Carsten Drachmann, CEO of GomSpace. The event will focus on GomSpace’s strategic direction and actions going forward on the back of the changed 2025 landscape, where nations are increasing spending and focus on space and security, and on which investments and actions taken during 2025 have positioned GomSpace to scale with ambition, in line with market dynamics going forward. The event will be followed by a Q&A session.

2025 has been a pivotal year for GomSpace. Market dynamics have shifted as public investments in space are set to increase, driven by a growing global desire for nations to own and control critical space assets alongside an elevated security agenda. This is already reflected in the results, also highlighted by the latest guidance update from December, where GomSpace now expects to deliver at the upper end of its guidance, with revenue of SEK 420–450m (SEK 257m in 2024) and at the upper end of an adjusted EBITDA margin of 7–13% (EBITDA margin of –10% in 2024).

Founded in 2007, GomSpace is a space company that manufactures and supplies hardware and software for satellite solutions within the nanosatellite and microsatellite segments.

Disclaimer: HC Andersen Capital receives payment from GomSpace for a Digital IR/Corporate Visibility subscription agreement. Michael Friis kl. 13.31 d. 13/01-2026.

Register for the event

Recent videos

Herantis Pharma Plc, Phase 1b biomarker data webcast
2026-01-08 11:00 Herantis Pharma
Investor Day | Nov. 24, 2025
2025-12-23 11:00 United Bankers
Uppesittarkväll 22/12 från Inderes Event Studio
2025-12-22 20:00
Talenom - Planned demerger and strategies of Talenom and Easor
2025-12-18 11:00 Talenom
Conference call with Fabege´s new CEO Bent Oustad
2025-12-18 10:00 Fabege
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.